Strategic Initiative

Slingshot members are tracking this corporate initiative:

Antares Pharma (ATRS) Enters into a Development Agreement with Pfizer (PFE) to develop a combination drug device rescue pen

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks



Additional Information

Additional Relevant Details This rescue pen will utilize the Antares QuickShot® auto injector and an undisclosed Pfizer drug. Pfizer will pay for the development of the product and will be responsible for obtaining FDA approval of the combination product. The parties intend to enter into a separate supply agreement pursuant to which Antares will provide fully packaged commercial ready finished product to Pfizer at cost plus margin and Pfizer will then be responsible for commercializing the product in the United States, pending FDA approval. Antares will then receive royalties on net sales on the combination product.
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Aug 06, 2018
Projected Implementation:
Q3, 2018
Relevance Tracked Until:
Q4, 2018
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Rescue Pen, Quickshot Testosterone